what is a peptide glp 1 Glucagon-like peptide-1 receptor The GLP-1 boom: Challenges, trends,

Description

Sarcopenia is an age-related syndrome characterized by a progressive and extensive decline in skeletal muscle mass and function, leading to serious impairment of the quality of life and poor health prognosis in older adults

With Novo Holdings $16.5 billion buyout of Catalent being reviewed by regulators, what work the contract drug manufacturer may or may not be performing for Eli Lilly remains a point of contention.

Thinking about a GLP-1

Diabetes GLP-1s Show Better Retention but Still Leak Demand GLP-1 therapies prescribed for type 2 diabetes demonstrate stronger patient retention than those indicated for obesity, but the market still faces substantial leakage